Bioethics: What Is It Good for? COVID-19 Vaccine Allocation Plans and Realities
It is clear that something was lost in the translation of vaccine allocation plans into reality. What went wrong?

The anti-vaccine movement is aggressively working to promote misinformation about COVID-19 vaccines.

Faced with limited COVID-19 vaccine doses and the ever-mounting toll of the pandemic, a new debate has emerged as to the best strategy for allocation.

If COVID-19 vaccines lead to any serious harms, society should compensate those victims generously and quickly.

Carmel Shachar, executive director of the Petrie-Flom Center, talks about the COVID-19 vaccine and who is likely to get it first.

We must remain cognizant of the many ways metaphors may distort, divide, or misrepresent important details.

We can simultaneously get COVID vaccines to those most at risk while minimizing harm to our ability to fully evaluate their safety and efficacy.

Paying for vaccination is dubious public health policy likely to backfire in terms of (re)building public trust in vaccines.

Can private businesses mandate that employees and customers receive COVID-19 vaccines authorized for emergency use?

In the past weeks, three companies in advanced stages of COVID-19 vaccine trials reported good news. What does this mean?
